MGA’s Alex Brill on CNBC’s Squawk Box

MGA’s Alex Brill on CNBC’s Squawk Box

MGA’s Alex Brill on CNBC’s Squawk Box On ‘Squawk Box’ today, Alex Brill discusses the second quarter GDP growth: “I think its a solid [GDP] number. Obviously, the inventory piece creates a little bit of volatility, and the investment numbers are a...
Shortened Exclusivity Could Save $31B

Shortened Exclusivity Could Save $31B

Shortened Exclusivity Could Save $31B Alex Brill was recently quoted by Politico Pro about MGA’s recent “Gamesmanship and Other Barriers to Drug Competition” paper: “Brand-name medicines’ market exclusivity periods have climbed an average...
Biologics are Not Natural Monopolies

Biologics are Not Natural Monopolies

Biologics are not Natural Monopolies Alex Brill and Benedic N. Ippolito | Health Affairs Blog Recently, several physicians and health policy analysts took to the Health Affairs blog to propose what was, to anyone who has been following biosimilars for the...